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Summary: Nitro-£-arginine is used as an inhibitor of nitric oxide synthase in many biological systems. Nitric oxide
(NO) is unstable and degrades to nitrite (NOJ") and nitrate (NOJ"). The colorimetric reaction of NO^~ with Griess
reagent is commonly used to measure NOf. NOf may be measured as NO£" following reduction by cadmium or
cadmium/copper. We found that bradykinin increased the formation of NO£~ by bovine coronary endothelial cells.
Nitro-L-arginine further increased the formation of NOi". This increase is due to the interference of nitro-L-arginine
in determination of NOf by the cadmium reduction to NO^~ and Griess reagent reaction. Incubation of nitro-L-
arginine with cadmium or cadmium/copper produced a product that reacts with Griess reagent to form a compound
that has an absorption spectrum identical to the product formed by NO^" and Griess reagent. Caution must be
exercised when using the NOf/NOf measurement by the Griess reaction to assess inhibition of nitric oxide synthase
by nitro-Z,-arginine.
Introduction
Nitric oxide (NO) is now recognized as an endothelium-
derived vasodilator and a possible neurotransmitter (1).
In biological systems, it is produced in very low concen-
trations, and it has a very short half-life (< 6 s) (2). Un-
der physiological conditions, NO may degrade to nitrite
(NOi~) and also nitrate (NOJ"). This, however, represents
only one of its inactivation pathways. Detection of
NO^~ and NOJ" is commonly used as an index of nitric
oxide synthase2) activity. A number of methods for NO,
NO£~ and NOJ" detection have been reported. Measure-
ments of reactive NO are made by chemiluminescence
using the reaction of NO with ozone (3, 4) or luminol-
hydrogen peroxide (5, 6) and by spectrophotometric as-
says based on the reaction with oxyhaemoglobin (7) or
Fe-S proteins (8). For measuring the more stable NOf
and NOJ", a Chromatographie method (7), a reaction of
NOf with Griess reagent followed by a spectrophoto-
metric detection (9, 10), an automated system with a
NQf-GWess reagent reaction (11, 12), and fluorometric
method (13) have been reported. With these spectropho-
tometric and fluorometric methods, NOJ~ has to be re-
duced to NO^T by nitrate reductase or more commonly
by % metal such as cadmium prior to the reaction with
the reagents.
During the study of the effects of nitro-L-arginine on
NO release from cultured endothelial cells, the NO^Y
NOJ" concentration was determined by cadmium (Cd)
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2) Enzyme: Nitric oxide synthase
reduction and Griess reagent reaction. We found that the
samples always produced more colour or apparent
NOJ in the presence than in the absence of nitro-Z,-argi-
nine. Preliminary data showed that the bradykinin stimu-
lation of bovine coronary artery endothelial cells
increased the production of NO^~. In the presence of ni-
tro-L-arginine, the production of NOJ increased further
rather than decreasing. This prompted us to investigate
the effects of nitro-Z,-arginine on this assay method and




and Cd powder (—100 mesh) were purchased from Aldrich Chemi-
cal Co. (Milwaukee. WI); NaNO2, NaNO3, D-arginine and L-argi-
nine from Sigma Chemical Co. (St. Louis, MO); nitro-L-arginine
from Sigma Chemical Co., Serva Feinbiochemica (Heidelberg,
Germany), and Schweizerhalle (South Plainfield, NJ); bradykinin
from BACHEM Bioscience Inc. (Philadelphia, PA); [3H]£-arginine
from Amersham (Arlington Heights, IL); all other chemicals and
reagents from Sigma Chemical Co. Amino-L-arginine was a gift
from Dr. Owen Griffith (Department of Biochemistry, Medical Col-
lege of Wisconsin, Milwaukee, WI). Distilled-deionized water was
used in this study. Precleaned plasticware with methanol and deion-
ized water was used for all solutions.
Determinat ion of ni t r i te in bovine coronary artery
endothel ial cells
Bovine coronary artery endothelial cells were cultured onto 6-well
plates as previously described (14). The cells were washed with
Hepes buffer and then incubated in 3 ml of buffer containing nitro-
L-arginine (30 μτηοΐ/l) or vehicle for 10 min at 37 °C. Then, brady-
kinin (1 μιηοΐ/l) was added, and the incubation continued for 2 h.
Following the incubation, the supernatant was removed for NOf/
NOJ" measurement and the cells were frozen for protein determine-
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tion (15). Total nitrite (NOf and NOf) was measured by the Griess
reaction (see below). The results were expressed as total nitrite
(pmol) and were normalized to the total amounts of protein. Cell-
free samples did not have protein content and they were compared
at the same volumes and concentrations of chemicals.
Ni t r i c oxide synthase assay
Bovine coronary artery endothelial cells were grown to confluence
on 225 cm2 flasks and lysed with a pH 7.4 buffer containing: Hepes
(11 mmol/1), sucrose (0.35 mol/1), EDTA (0.1 mmol/1), dithiothrei-
tol (1 mmol/1), leupeptin (10 mg/1), aprotinin (2mg/l), soybean
trypsin inhibitor (10 mg/1), phenylmethylsulphonyl fluoride (10
mg/1), NP-40 (10 g/1), and glycerol (100 g/1). The conversion of
[3H]arginine to [3H]citrulline was used as an index of nitric oxide
synthase activity. The reaction volume was 100 μΐ in pH 7.5 buffer
containing: Tris-HCl (50 mmol/1), EDTA (0.1 mmol/1), EGTA (0.1
mmol/1), mercaptoethanol (lg/1), leupeptin (100 μπιοΐ/ΐ), phenyl-
methylsulphonyl fluoride (1 mmol/1), soybean trypsin inhibitor (10
mg/1), aprotinin (2 mg/1), calmodulin (10 nmol/1), NADPH
(1 mmol/1), tetraliydrobiopterin (3 μπιοΐ/ΐ), Ζ,-arginine (10 μπιοΐ/ΐ),
[3H]L-arginine (7.4 kBq, 2.52 TBq/mmol), calcium chloride (2.5
mmol/1), and 100 μg protein. Nitro-L-arginine was added to some
tubes at a final concentration of 30 μπιοΐ/ΐ. All samples were incu-
bated for 15 min at 37 °C in a shaking water bath and the reaction
was stopped by the addition of 1 ml of ice-cold pH 5.5 STOP
buffer containing: Hepes (20 mmol/1), EDTA (2 mmol/1), and
EGTA (2 mmol/1). The [3H]citrulline was separated from the
[3H]arginine by passing the sample over an equilibrated Dowex
cation exchange column (Na+ form). Nitric oxide synthase activity
is expressed as Bq of citrulline.
Ni t ra te /ni t r i te determination
All NOi", NOj and NOf/NOf standards and samples were pre-
pared in pH 7.4 Hepes buffer consisting of Hepes (10 mmol/l),
NaCl (150 mmol/1), KC1 (5 mmol/1), CaCl2 (2 mmol/1), MgCl2
(1 mmol/1) and glucose (5 mmol/1). Nitrate was reduced to NOi"
by incubating 1 ml of the solution with approximately 0.05 g of
Cd powder for different periods of time, generally 15 min. To this
incubation, 5 μΐ of 10% HC1 were added, and the solution was
centrifuged for a few minutes to separate the Cd. The supernatant
of 800 μΐ was transferred to a small tube. A 25 μΐ of 5 g/1 sulphanil-
amide in 2 mol/1 HC1 was added and mixed. Then, 25 μΐ of 3 g/1
naphthylethylenediamine dihydrochloride in 0.1 mol/1 HC1 were
added, mixed and allowed to react for 15 min. Two aliquots of 350
μΐ were transferred to 96-well microplate and the absorbance was
measured at 540 nm on Microplate Autoreader (Bio-Tek Instru-
ment, Winooski, VT). The absorbance was the average of two wells
for each sample. Nitrite was treated the same way as NOf but
without the Cd. Absorbance of Hepes buffer blanks treated with
Cd were subtracted from all measurements. Results were expressed
as apparent NOJ (μπιοΐ/ΐ). . f
High performance liquid chromatography
Chromatography was performed on a 1090 Series II Hewlett Pack-
ard Liquid Chromatograph (Hewlett Packard Co., Palo Alto, CA).
Three types of columns and gradient programmes were used for
separation of nitro-L-arginine and its Cd catalyzed product(s);
(a) an ODS Ci8 column (5 μιη, 100 X 2.1 mm) (Hewlett Packard
Co., Palo Alto, CA) with a 3 min 0 to 15% acetonitrile in water
elution gradient;
(b) a Nucleosil Cig column (5 μηι, 250 X 10 mm) (Phenornenex,
Torrance, CA) with a 5 min 0 to 10% acetonitrile in water elution
gradient; and
(c) a Nucleosil 5 NH2 column (5 μπι, 250 X 4.6 mm) (Pheno-
rnenex) with 60% acetonitrile/40% water with 0.1 mol/1 ammo-
nium acetate elution solvent.
The absorbance was detected by a Hewlett Packard model 1040
photodiode array detector, and the chromatograms were recorded
at 275 mm with 10 nm bandwidth and reference wavelength of 450
nm with 20 nm bandwidth. Full UV absorbance spectra (200^-400
nm) were obtained during the HPLC analysis every 6 s and stored
on a Hewlett Packard ChemStation for later analysis. The product
peak fraction was collected and reacted with Griess reagent or
otherwise analyzed.
Results and Discussion
It has been shown that bradykinin stimulated the NO
production of endothelial cells (16) and the nitro-L-argi-
nine was a potent inhibitor of the nitric oxide synthase
(17, 18). Preliminary data show that bradykinin stim-
ulated total NOi (NOf + NOf) production by cultured
endothelial cells (fig. la). However, preincubation of the
2000-1
Fig.J a) Effect of nitro-L-arginine and bradykinin on total
NOJ (NOJ + NOf) by bovine coronary endothelial cells. These
data are normalized to the total protein content. Also shown are
cell-free incubations with bradykinin. The data for cell-free incub-
ations are compared at the same volumes and concentrations of
chemicals. Each value represents the mean ± S. E. (n = 6).
b) Nitric oxide synthase activity (expressed as Bq per volume unit)
of endothelial cells (control) and in the presence of nitro-L-argi-
nine. (n = 3).
Nithipatikom et al.: Nitro-L-arginine interferes nitrate measurement 135
cells with the nitric oxide synthase inhibitor, nitro-L-
arginine, increased instead of decreased NOJ pro-
duction. In contrast, nitro-L-arginine markedly inhibited
the nitric oxide synthase activity in the cells (fig. Ib).
The total NOf (NOJ + NOf) in mfcdia (cell free) was
also increased by nitro-L-arginine (fig. la). These data
indicate that nitro-L-arginine actually inhibits NO pro-
duction by endothelial cells and suggests that nitro-L-
arginine may interfere with the assay for NOf by cad-
mium reduction and Griess reaction.
Standards of NOJ, NOf or a mixture of equimolar
amounts of NOJ and NOf were prepared. The samples
containing NOf were treated with Cd and reduced to
NO£~. The samples were then reacted with Griess rea-
gent, and the absorbance was measured. The standard
curves are shown in figure 2a. The absorbance of the
three sets of standards were superimposable for every
concentration indicating that the experimental condi-
tions were acceptable for the assay of NOS". The possible
interference of impurities in Hepes buffer and the Cd
was investigated by incubating various amounts of Cd
powder in water or Hepes buffer for 15 min, adding
Griess reagent to the aliquots and measuring absorbance.
More apparent NOJ, i. e., greater absorbance, was mea-
sured with increasing amounts of Cd. The absorbance
was slightly greater in Hepes buffer than in water. How-
ever, the amount of colour detected as NOJ in the water
and Hepes buffer was far less than (over 100 times) that
measured in subsequent experiment with nitro-L-argi-
nine. D-Arginine, L-arginine, amino-L-arginine, and ni-
tro-L-arginine from several sources were incubated in
Hepes buffer with and without Cd. Arginine analogs
without the nitro-group did not produce measurable
NO£~ with Griess reagent when incubated in the pres-
ence or absence of Cd (fig. 2b). In contrast, large
amounts of apparent NO^~ were measured when nitro-L-
arginine was incubated with Cd. No NO^" was detected
when nitro-L-arginine was not treated with Cd. Nitro-L-
arginine from different suppliers gave similar results.
The nitro-L-arginine-Cd incubation solution was puri-
fied by HPLC to eliminate any possible impurity, includ-
ing NOJ", and the peak fractions were collected and re-
acted with Griess reagent. The fraction containing unre-
acted nitro-L-arginine did not produce the colour while
the fraction containing the reaction product gave the col-
our with Griess reagent. This shows that an impurity in
nitro-L-arginine could not account for the colour pro-
duction. The concentrations of apparent NOJ increased
with increasing amounts of nitro-L-arginine. Incubation
of nitro-L-arginine in Hepes buffer with Cd produced
apparent NOJ immediately (data not shown) and the
apparent NOf concentration did not increase with a
longer incubation time up to 3 h, The apparent NOJ was
also observed in the incubation of nitro-L-arginine with
Cd/Cu amalgam or by adding nitro-L-arginine to the
flow through of a Cd column used with an HPLC or an
automated NOj/NOf flow injection analyzer (19).
To identify the product(s) from the incubation of nitro-
L-arginine with Cd, the incubation solution was ana-
lyzed by HPLC, and the compounds were separated on
a Cig or amino propyl column. Nitro-L-arginine gave a
single peak on HPLC that eluted on the ODS C18 col-
umn at l min and on the Nucleosil Qg column at 7.8
min. Following Cd treatment, two peaks were observed,
the nitro-L-arginine peak and a Cd-derived reaction pro-
duct peak. The reaction product was more polar than
nitro-L-arginine and eluted at 0.6 min on the ODS Cig
column and at 5.5 min on the Nucleosil C18 column. The
retention time of the reaction product was greater than
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Fig. 2 a) Typical standard curves of NO2 (square), N 3 (circle),
and an equimolar mixture of NOf and NOf (triangle). Nitrate was
reduced to NOJ with Cd and measured by the Griess reaction.
Nitrite was measured directly by the Griess reaction,
b) Apparent NOf production from incubation of argintnes (1.0
mmol/1) with Cd in Hepes buffer. Shown are D-arginine, L-argi-
nine, amino-L-arginine, nitro-L-argininc l (Schweizerhalle), nitro-
L-arginine 2 (Serva Feinbiochemica), nitro-L-arginine 3 (Sigma
Chemical Co.), nitro-L-arginine 4 (Serva Feinbiochcmica without
Cd). Each value represents the average of 2 sets of duplicate deter-
minations.




Fig. 3 a) Chromatogram of the incubation of nitro-I-arginine
with Cd separated on the Nucleosil 5 NH2 column (see text). The
first peak (I) at 14.2 min corresponds to nitro-i.-arginine retention
time, the second peak (II) at 17.3 min is the reaction product.
250 300 350 400
Wavelength [nm]
b) UV absorption spectra taken from the peaks of chromatograms
during the analysis. The solid line (I) is the spectrum of nitro-L-
arginine (the first peak) and the dashed line (II) is the spectrum of
the reaction product (the second peak). The spectra are normalized
at the absorption maxima.
versus 14.2 min for nitro-L-arginine) (fig. 3a). The ab-
sorption maximum of the reaction product was shifted
from 270 nm for nitro-L-arginine to 255 nm with a weak
absorption peak at 350 nm (fig. 3b). This product also
had a light yellow colour. The retention time and UV
absorbance of this product did not match i-arginine or
any of the arginine analogs used in this study. The reac-
tion product of nitro-L-arginine with Cd was isolated by
HPLC and added to the Griess reagent. It formed a col-
oured adduct that had the same visible spectrum as the
one formed in the reaction of NOi" with the Griess rea-
gent (absorbance maxima of 543 nm). We therefore call
the colour or absorbance produced by the Cd-derived
reaction product "apparent NO^"". The identity of this
reaction product is not known.
In conclusion, the incubation of nitro-L-arginine with
Cd generates a product, possibly products, that appears
responsible for the apparent NO^~ that was determined
by the reaction with Griess reagent. These data indicate
that nitro-L-arginine will interfere with the measurement
of NOj". Detection of NO^~ and NO J" is commonly used
as an index of nitric oxide syrithase activity even though
these ions are not the only products of NO degradation
(12, 20). Interference Of nitro-L-arginine with the detec-
tion of NOf will further complicate this relationship.
For this reason, caution should be used when using the
NO^~/NOf measurement by the Griess reaction to assess
inhibition of nitric oxide synthase by nitro-L-arginine.
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